Stephen Pendergast/LinkedIn
Apr 22, 2026, 15:22
Stephen Pendergast: Are Universal Shelf Stable Blood Substitutes Finally Within Reach?
Stephen Pendergast, Consultant in Systems Engineering (Radar, Data Links, and Satellite Communications) and Senior Systems Engineer, shared a post on LinkedIn:
“Researchers at Japan’s Nara Medical University have engineered hemoglobin vesicles that work for blood transfusion replacements all blood types and last for years.
As clinical trials advance, parallel efforts in the U.S. and U.K. are converging on a long-elusive goal: a shelf-stable substitute for donated blood.
This could revolutionize emergency room and battlefield emergency care.”
Stay updated with Hemostasis Today.
-
Apr 22, 2026, 14:51Mavis Agnes Kisakye: Reconnecting to Drive the Global Bleeding Disorders Agenda Forward
-
Apr 22, 2026, 14:48Augustina Isioma Ikusemoro: Not Every Antigen Speaks Loudly But the Right Test Will Hear It
-
Apr 22, 2026, 14:47Karuna Kumar: Busting the Myth about Increasing Infection Risk by IV Iron
-
Apr 22, 2026, 14:46David Brown: Charting a New Path Forward for One Patient Facing Extraordinary Cardiac Challenges
-
Apr 22, 2026, 14:45Ney Carter Borges: Syphilis and Cardiovascular Risk – A Silent and Progressive Vascular Burden
-
Apr 22, 2026, 14:44Sanjay Ahuja – New CEO and Medical Director of Innovative Hematology
-
Apr 22, 2026, 14:36Shivanand Kumatagi: Building Clinical Research Skills at the ASH CRTI Asia Pacific Program
-
Apr 22, 2026, 14:22Pradeep Natarajan: Can Polygenic Risk Scores Refine Risk Stratification in Secondary Prevention of CAD
-
Apr 22, 2026, 14:16Omar Adwan: Rare Genetic Disorders of Red Blood Cell Membrane Abnormalities